ANVSNYSEPharmaceutical PreparationsFiscal year ends December 31
Annovis Bio, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.96−0.03 (-3.36%)
Close on Oct 19, 2026
- Market cap
- $36.02M
- P/E (TTM)
- –
- Dividend yield
- –
Annovis Bio statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Annovis Bio | Industry median |
|---|---|---|
| Market Cap | $40.90M | $166.30M |
| Enterprise Value | $22.17M | $88.19M |
Income (trailing twelve months)
| Measure | Annovis Bio | Industry median |
|---|---|---|
| Revenue | $0 | $58.34M |
| Operating Income | -$49.53M | -$21.40M |
| Net Income | -$49.52M | -$22.46M |
| EBITDA | -$49.53M | -$16.91M |
| EPS (Diluted) | -$1.78 | -$0.83 |
Returns
| Measure | Annovis Bio | Industry median |
|---|---|---|
| Return on Equity (ROE) | -703.7% | -53.2% |
| Return on Assets (ROA) | -227.7% | -40.9% |
| Return on Capital Employed (ROCE) | -315.9% | -38.1% |
Balance sheet
| Measure | Annovis Bio | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $18.73M | $61.43M |
| Net Cash (Debt) | $18.73M | $15.35M |
| Net Cash Per Share | $0.44 | $0.66 |
| Equity (Book Value) | -$4.25M | $49.09M |
| Book Value Per Share | -$0.10 | $1.37 |
| Tangible Book Value | -$4.25M | $23.52M |
Financial position
| Measure | Annovis Bio | Industry median |
|---|---|---|
| Quick Ratio | 2.95 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Annovis Bio | Industry median |
|---|---|---|
| Operating Cash Flow | -$43.34M | -$12.35M |
Efficiency
| Measure | Annovis Bio | Industry median |
|---|---|---|
| Asset Turnover | 0.00 | 0.39 |
| Revenue Per Employee | $0 | $404.87K |
| Profits Per Employee | -$6.19M | -$703.34K |
| Employee Count | 8 | 74 |
Dividends and yields
| Measure | Annovis Bio | Industry median |
|---|---|---|
| Earnings Yield | -121.1% | -23.3% |
Shares
| Measure | Annovis Bio | Industry median |
|---|---|---|
| Shares Outstanding | 42,606,200 | 58,127,000 |
| Shares Change (YoY) | 71.7% | 10.9% |
| Shares Change (QoQ) | 49.3% | 0.54% |
| Float | 37,837,300 | 49,136,700 |
| Shares Held by Insiders | 11.2% | 11.6% |
| Shares Held by Institutions | 25.5% | 59.4% |
Taxes
| Measure | Annovis Bio | Industry median |
|---|---|---|
| Income Tax | $0 | $79.87K |
Scores
| Measure | Annovis Bio | Industry median |
|---|---|---|
| Altman Z-Score | -18.94 | -0.22 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from Annovis Bio's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.